Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

L Klimek1, A M Chaker2, M Cuevas3

  • 1Zentrum für Rhinologie und Allergologie, Wiesbaden.

Laryngo- Rhino- Otologie
|March 8, 2021
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Graphene-plasmon-mediated coherent dynamics in an N-quantum-emitter system.

Optics express·2026
Same author

Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

Allergy·2026
Same author

[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].

Laryngo- rhino- otologie·2026
Same author

Correspondence: First Peanut (Arachis hypogaea) Allergen Oral Immunotherapy Product Out of Sale-A Major Drawback for Food Allergy Immunotherapy?

Allergy·2026
Same author

[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 3: Hypersensitivity reactions of type VI].

HNO·2026
Same author

The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position Paper.

Allergy·2026
Same journal

Guideline-Based Cochlear Implant Care: A Model for Structuring Delegated Technical Aftercare.

Laryngo- rhino- otologie·2026
Same journal

Audiometric evaluation and quality-of-life in OSIA users - a retrospective monocentric study.

Laryngo- rhino- otologie·2026
Same journal

[Diagnosis and treatment of vestibular migraine - recent developments and future treatment strategies].

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
See all related articles

Allergic reactions to mRNA COVID-19 vaccines are rare but possible, particularly in sensitized individuals. Allergy experts confirm that atopic or venom allergies do not increase anaphylaxis risk from COVID vaccination.

Area of Science:

  • Immunology
  • Vaccinology
  • Allergy and Clinical Immunology

Background:

  • mRNA COVID-19 vaccines are widely administered.
  • Anaphylaxis, a severe allergic reaction, is an uncommon but potential adverse event.
  • Individuals sensitized to vaccine components may be at higher risk.

Purpose of the Study:

  • To outline diagnostic strategies for potential allergic reactions to mRNA COVID-19 vaccines.
  • To provide guidance on the prevention, recognition, and management of anaphylaxis post-vaccination.
  • To identify high-risk populations and discuss pre-vaccination allergy assessments.

Main Methods:

  • Review of current literature and expert opinion on anaphylaxis following mRNA COVID-19 vaccination.
  • Discussion of diagnostic approaches, including allergy testing.

Related Experiment Videos

  • Consideration of risk stratification and management protocols.

    • Main Results:

    • Anaphylaxis is a rare but significant concern due to the large-scale vaccination effort.
    • Specific diagnostic pathways and therapeutic interventions for vaccine-induced anaphylaxis are crucial.
    • Patients with atopic or venom allergies are not considered at increased risk for anaphylaxis from COVID-19 vaccination.

    Conclusions:

    • Proactive identification and management of anaphylaxis are essential for safe mRNA COVID-19 vaccine rollout.
    • Pre-vaccination allergy evaluations are recommended for specific patient groups.
    • Current evidence suggests that common allergies do not contraindicate COVID-19 vaccination.